167 related articles for article (PubMed ID: 22281910)
1. Hypertrophic perianal herpes successfully treated with imiquimod.
Lestre SI; João A; Carvalho C; Serrão VV
An Bras Dermatol; 2011; 86(6):1185-8. PubMed ID: 22281910
[TBL] [Abstract][Full Text] [Related]
2. Atypical presentations of genital herpes simplex virus in HIV-1 and HIV-2 effectively treated by imiquimod.
McKendry A; Narayana S; Browne R
Int J STD AIDS; 2015 May; 26(6):441-3. PubMed ID: 24912536
[TBL] [Abstract][Full Text] [Related]
3. Association of oral acyclovir and imiquimod for the treatment of hypertrophic genital herpes simplex in HIV positive patients: report of two cases.
Barbosa Ldo N; Souto R; Furtado AL; Gripp AC; Daxbacher E
An Bras Dermatol; 2011; 86(5):1043-5. PubMed ID: 22147057
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics of hypertrophic herpes simplex genitalis and treatment outcomes of imiquimod: a retrospective observational study.
Leeyaphan C; Surawan TM; Chirachanakul P; Prasertworonun N; Punyaratabandhu P; Omcharoen V; Jiamton S
Int J Infect Dis; 2015 Apr; 33():165-70. PubMed ID: 25660091
[TBL] [Abstract][Full Text] [Related]
5. Recalcitrant hypertrophic herpes genitalis in HIV-infected patient successfully treated with topical imiquimod.
Tandon S; Singh J; Sinha S; Sharma DP
Dermatol Ther; 2017 May; 30(3):. PubMed ID: 28261899
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of hypertrophic herpes simplex genitalis in HIV-infected patient with topical imiquimod.
Deza G; Martin-Ezquerra G; Curto-Barredo L; Villar García J; Pujol RM
J Dermatol; 2015 Dec; 42(12):1176-8. PubMed ID: 26074211
[TBL] [Abstract][Full Text] [Related]
7. Selective defect in plasmacyoid dendritic cell function in a patient with AIDS-associated atypical genital herpes simplex vegetans treated with imiquimod.
Abbo L; Vincek V; Dickinson G; Shrestha N; Doblecki S; Haslett PA
Clin Infect Dis; 2007 Feb; 44(3):e25-7. PubMed ID: 17205432
[TBL] [Abstract][Full Text] [Related]
8. Recalcitrant pseudotumoral anogenital herpes simplex virus type 2 in HIV-infected patients: evidence for predominant B-lymphoplasmocytic infiltration and immunomodulators as effective therapeutic strategy.
Sbidian E; Battistella M; Legoff J; Lafaurie M; Bézier M; Agbalika F; Simon F; Bouscarat F; Cayuela JM; Carcelain G; Houhou N; Bagot M; Molina JM; Janier M; Bachelez H
Clin Infect Dis; 2013 Dec; 57(11):1648-55. PubMed ID: 24065320
[TBL] [Abstract][Full Text] [Related]
9. Progressive hypertrophic genital herpes in an HIV-infected woman despite immune recovery on antiretroviral therapy.
Yudin MH; Kaul R
Infect Dis Obstet Gynecol; 2008; 2008():592532. PubMed ID: 18784844
[TBL] [Abstract][Full Text] [Related]
10. Hypertrophic genital herpes in an HIV-infected female patient: Imiquimod as an alternative treatment.
Barroso Dos Reis HL; Tosato Boldrini NA; da Silva Campos LC; Campos LG; Salume Costa FL; Jacomele Caldas JV; Pedras Almeida SL; Miranda AE
Int J Infect Dis; 2020 Jun; 95():153-156. PubMed ID: 32311452
[TBL] [Abstract][Full Text] [Related]
11. Time to refocus on HSV interventions for HIV prevention?
Tanton C; Abu-Raddad LJ; Weiss HA
J Infect Dis; 2011 Dec; 204(12):1822-6. PubMed ID: 21998480
[No Abstract] [Full Text] [Related]
12. Herpes Simplex Virus Suppressive Therapy in Herpes Simplex Virus-2/Human Immunodeficiency Virus-1 Coinfected Women Is Associated With Reduced Systemic CXCL10 But Not Genital Cytokines.
Andersen-Nissen E; Chang JT; Thomas KK; Adams D; Celum C; Sanchez J; Coombs RW; McElrath MJ; Baeten JM
Sex Transm Dis; 2016 Dec; 43(12):761-764. PubMed ID: 27832025
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of aciclovir and foscarnet resistant Herpes simplex virus lesions with topical imiquimod in patients infected with human immunodeficiency virus type 1.
Lascaux AS; Caumes E; Deback C; Melica G; Challine D; Agut H; Lévy Y
J Med Virol; 2012 Feb; 84(2):194-7. PubMed ID: 22170537
[TBL] [Abstract][Full Text] [Related]
14. Bipolar hypertrophic herpes: an unusual presentation of acyclovir-resistant herpes simplex type 2 in a HIV-infected patient.
Cury K; Valin N; Gozlan J; Jacquier I; Boutolleau D; Guegan S; Flejou JF; Girard PM
Sex Transm Dis; 2010 Feb; 37(2):126-8. PubMed ID: 19858782
[TBL] [Abstract][Full Text] [Related]
15. Surgical excision for recurrent herpes simplex virus 2 (HSV-2) anogenital infection in a patient with human immunodeficiency virus (HIV).
Arinze F; Shaver A; Raffanti S
Infection; 2017 Oct; 45(5):705-707. PubMed ID: 28508238
[TBL] [Abstract][Full Text] [Related]
16. A randomized controlled pilot trial of valacyclovir for attenuating inflammation and immune activation in HIV/herpes simplex virus 2-coinfected adults on suppressive antiretroviral therapy.
Yi TJ; Walmsley S; Szadkowski L; Raboud J; Rajwans N; Shannon B; Kumar S; Kain KC; Kaul R; Tan DH
Clin Infect Dis; 2013 Nov; 57(9):1331-8. PubMed ID: 23946220
[TBL] [Abstract][Full Text] [Related]
17. Impact of acyclovir on genital and plasma HIV-1 RNA, genital herpes simplex virus type 2 DNA, and ulcer healing among HIV-1-infected African women with herpes ulcers: a randomized placebo-controlled trial.
Mayaud P; Legoff J; Weiss HA; Grésenguet G; Nzambi K; Bouhlal H; Frost E; Pépin J; Malkin JE; Hayes RJ; Mabey DC; Bélec L;
J Infect Dis; 2009 Jul; 200(2):216-26. PubMed ID: 19530940
[TBL] [Abstract][Full Text] [Related]
18. Valacyclovir for the suppression of recurrent genital herpes in human immunodeficiency virus-infected subjects.
DeJesus E; Wald A; Warren T; Schacker TW; Trottier S; Shahmanesh M; Hill JL; Brennan CA;
J Infect Dis; 2003 Oct; 188(7):1009-16. PubMed ID: 14513421
[TBL] [Abstract][Full Text] [Related]
19. Atypical Presentation of Herpes Simplex Virus Type 2 Infection Refractory to Treatment With Aciclovir in 2 Hematologic Patients.
Nieto Rodríguez D; Sendagorta Cudós E; Rueda Carnero JM; Herranz Pinto P
Actas Dermosifiliogr (Engl Ed); 2019 Jun; 110(5):393-397. PubMed ID: 29203034
[TBL] [Abstract][Full Text] [Related]
20. Treatment of primary herpes simplex virus infection in guinea pigs by imiquimod.
Miller RL; Imbertson LM; Reiter MJ; Gerster JF
Antiviral Res; 1999 Nov; 44(1):31-42. PubMed ID: 10588331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
